Skip to main content
Erschienen in: Endocrine 2/2015

01.03.2015 | Original Article

Nodal metastasis and recurrence in papillary thyroid microcarcinoma

verfasst von: Adolfo Pisanu, Alessandra Saba, Mauro Podda, Isabella Reccia, Alessandro Uccheddu

Erschienen in: Endocrine | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Despite the majority of papillary thyroid microcarcinoma (PTMC) patients has benign clinical courses, some PTMCs have a clinical presentation similar to conventional papillary thyroid carcinoma (PTC). The aim of this study was to identify risk factors for lymph node metastasis at presentation and prognostic parameters influencing nodal recurrence in PTMC. From January 1998 to October 2013, 556 consecutive patients had a diagnosis of differentiated thyroid carcinoma in our surgical department. A total of 219 (39.4 %) patients who had a pathological diagnosis of PTMC represented the cohort for the current study. We carried out a retrospective cohort study to compare 24 PTMC patients with lymph node metastasis at diagnosis (N1) and 195 PTMC patients without lymph node involvement (N0). The comparison between groups involved evaluation of patients and tumor characteristics. A diameter >8 mm, the presence of multifocality, and extrathyroid invasion (T3) were independent risk factors for nodal involvement at presentation. The presence of T3 was the only independent prognostic parameter influencing nodal recurrence. Prognostic factors for N1 at presentation and for recurrence are pathological parameters, thus it is not possible before surgery to detect PTMC patients who are at risk. However, we believe that a full treatment protocol should be also indicated in the case of PTMC according to risk stratification and cancer stage as for the conventional counterpart of PTC.
Literatur
1.
Zurück zum Zitat R.A. DeLellis, R.V. Lloyd, P.U. Heitz, Pathology and genetics of tumors of endocrine organs, in World Health Organization classification of tumors, ed. by R.A. DeLellis, R.V. Lloyd, et al. (IARC Press, Lyon, 2004), pp. 64–66 R.A. DeLellis, R.V. Lloyd, P.U. Heitz, Pathology and genetics of tumors of endocrine organs, in World Health Organization classification of tumors, ed. by R.A. DeLellis, R.V. Lloyd, et al. (IARC Press, Lyon, 2004), pp. 64–66
2.
Zurück zum Zitat S.B. Edge, C.C. Compton, The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 17, 1471–1474 (2010)CrossRefPubMed S.B. Edge, C.C. Compton, The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 17, 1471–1474 (2010)CrossRefPubMed
3.
Zurück zum Zitat Y. Ito, T. Uruno, K. Nakano, Y. Takamura, A. Miya, K. Kobayashi, T. Yokozawa, F. Matsuzuka, S. Kuma, K. Kuma, A. Miyauchi, An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13, 381–387 (2003)CrossRefPubMed Y. Ito, T. Uruno, K. Nakano, Y. Takamura, A. Miya, K. Kobayashi, T. Yokozawa, F. Matsuzuka, S. Kuma, K. Kuma, A. Miyauchi, An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13, 381–387 (2003)CrossRefPubMed
4.
Zurück zum Zitat E. Baudin, J.P. Travagli, J. Ropers, F. Mancusi, G. Bruno-Bossio, B. Caillou, A.F. Cailleux, J.D. Lumbroso, C. Parmentier, M. Schlumberger, Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer 83, 553–559 (1998)CrossRefPubMed E. Baudin, J.P. Travagli, J. Ropers, F. Mancusi, G. Bruno-Bossio, B. Caillou, A.F. Cailleux, J.D. Lumbroso, C. Parmentier, M. Schlumberger, Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer 83, 553–559 (1998)CrossRefPubMed
5.
Zurück zum Zitat E. Roti, R. Rossi, G. Trasforini, F. Bertelli, M.R. Ambrosio, L. Busutti, E.N. Pearce, L.E. Braverman, E.C. Degli Uberti, Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J. Clin. Endocrinol. Metab. 91, 2171–2178 (2006)CrossRefPubMed E. Roti, R. Rossi, G. Trasforini, F. Bertelli, M.R. Ambrosio, L. Busutti, E.N. Pearce, L.E. Braverman, E.C. Degli Uberti, Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J. Clin. Endocrinol. Metab. 91, 2171–2178 (2006)CrossRefPubMed
6.
Zurück zum Zitat J.Y. Kwak, E.-K. Kim, M.J. Kim, E.J. Son, W.Y. Chung, C.S. Park, K.-H. Nam, Papillary microcarcinoma of the thyroid: predicting factors of lateral neck node metastasis. Ann. Surg. Oncol. 16, 1348–1355 (2009)CrossRefPubMed J.Y. Kwak, E.-K. Kim, M.J. Kim, E.J. Son, W.Y. Chung, C.S. Park, K.-H. Nam, Papillary microcarcinoma of the thyroid: predicting factors of lateral neck node metastasis. Ann. Surg. Oncol. 16, 1348–1355 (2009)CrossRefPubMed
7.
Zurück zum Zitat I.D. Hay, E.J. Bergstralh, J.R. Goelner, J.R. Ebersold, C.S. Grant, Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114, 1050–1058 (1993)PubMed I.D. Hay, E.J. Bergstralh, J.R. Goelner, J.R. Ebersold, C.S. Grant, Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114, 1050–1058 (1993)PubMed
8.
Zurück zum Zitat S.M. Chow, S.C.K. Law, J.K. Chan, S.K. Au, S. Yau, W.H. Lau, Papillary microcarcinoma of the thyroid. Prognostic significance of lymph node metastasis and multifocality. Cancer 98, 31–40 (2003)CrossRefPubMed S.M. Chow, S.C.K. Law, J.K. Chan, S.K. Au, S. Yau, W.H. Lau, Papillary microcarcinoma of the thyroid. Prognostic significance of lymph node metastasis and multifocality. Cancer 98, 31–40 (2003)CrossRefPubMed
10.
Zurück zum Zitat I.D. Hay, C.S. Grant, J.A. van Heerden, J.R. Goellner, J.R. Ebersold, E.J. Bergstralh, Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112, 1139–1146 (1992)PubMed I.D. Hay, C.S. Grant, J.A. van Heerden, J.R. Goellner, J.R. Ebersold, E.J. Bergstralh, Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112, 1139–1146 (1992)PubMed
11.
Zurück zum Zitat N. Wada, Q.Y. Duh, K. Sugino, H. Iwasaki, K. Kameyama, T. Mimura, K. Ito, H. Takami, Y. Takanashi, Lymph node metastasis from 259 papillary thyroid microcarcinomas. Frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann. Surg. 237, 399–407 (2003)PubMedCentralPubMed N. Wada, Q.Y. Duh, K. Sugino, H. Iwasaki, K. Kameyama, T. Mimura, K. Ito, H. Takami, Y. Takanashi, Lymph node metastasis from 259 papillary thyroid microcarcinomas. Frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann. Surg. 237, 399–407 (2003)PubMedCentralPubMed
12.
Zurück zum Zitat K.D. Lin, J.D. Lin, M.J. Huang, H.S. Huang, L.B. Jeng, T.C. Chao, Y.S. Ho, Clinical presentations and predictive variables of thyroid microcarcinoma with distant metastasis. Int. Surg. 82, 378–381 (1997)PubMed K.D. Lin, J.D. Lin, M.J. Huang, H.S. Huang, L.B. Jeng, T.C. Chao, Y.S. Ho, Clinical presentations and predictive variables of thyroid microcarcinoma with distant metastasis. Int. Surg. 82, 378–381 (1997)PubMed
13.
Zurück zum Zitat Y. Ito, T. Jikuzono, T. Higashiyama, S. Asahi, C. Tomoda, Y. Takamura, A. Miya, K. Kobayashi, F. Matsuzuka, K. Kuma, A. Miyauchi, Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J. Surg. 30, 1821–1828 (2006)CrossRefPubMed Y. Ito, T. Jikuzono, T. Higashiyama, S. Asahi, C. Tomoda, Y. Takamura, A. Miya, K. Kobayashi, F. Matsuzuka, K. Kuma, A. Miyauchi, Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J. Surg. 30, 1821–1828 (2006)CrossRefPubMed
14.
Zurück zum Zitat C. Cappelli, M. Castellano, M. Braga, E. Gandossi, I. Pirola, E. De Martino, B. Agosti, E.A. Rosei, Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience. J. Surg. Oncol. 95, 555–560 (2007)CrossRefPubMed C. Cappelli, M. Castellano, M. Braga, E. Gandossi, I. Pirola, E. De Martino, B. Agosti, E.A. Rosei, Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono-institutional experience. J. Surg. Oncol. 95, 555–560 (2007)CrossRefPubMed
15.
Zurück zum Zitat N. Arora, H.K. Turbedian, M.A. Kato, T.A. Moo, R. Zarnegar, T.J. Fahey 3rd, Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid 5, 473–477 (2009)CrossRef N. Arora, H.K. Turbedian, M.A. Kato, T.A. Moo, R. Zarnegar, T.J. Fahey 3rd, Papillary thyroid carcinoma and microcarcinoma: is there a need to distinguish the two? Thyroid 5, 473–477 (2009)CrossRef
16.
Zurück zum Zitat J.P. Vandenbroucke, E. von Elm, D.G. Altman, P.C. Gøtzsche, C.D. Mulrow, S.J. Pocock, C. Poole, J.J. Schlesselman, M. Egger, Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS. Med. 4, e297 (2007). doi:10.1371/journal.pmed CrossRefPubMedCentralPubMed J.P. Vandenbroucke, E. von Elm, D.G. Altman, P.C. Gøtzsche, C.D. Mulrow, S.J. Pocock, C. Poole, J.J. Schlesselman, M. Egger, Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS. Med. 4, e297 (2007). doi:10.​1371/​journal.​pmed CrossRefPubMedCentralPubMed
17.
Zurück zum Zitat A. Pisanu, I. Reccia, O. Nardello, A. Uccheddu, Risk factors for nodal metastasis and recurrence among patients with papillary thyroid microcarcinoma: differences in clinical relevance between nonincidental and incidental tumors. World J. Surg. 33, 460–468 (2009)CrossRefPubMed A. Pisanu, I. Reccia, O. Nardello, A. Uccheddu, Risk factors for nodal metastasis and recurrence among patients with papillary thyroid microcarcinoma: differences in clinical relevance between nonincidental and incidental tumors. World J. Surg. 33, 460–468 (2009)CrossRefPubMed
18.
Zurück zum Zitat J. Schonberger, J. Marienhagen, A. Agha, S. Rozeboom, E. Bachmeier, H. Schlitt, C. Eilles, Papillary microcarcinoma and papillary cancer of the thyroid B1 cm. Modified definition of the WHO and the therapeutic dilemma. Nuklearmedizin 46, 115–120 (2007)PubMed J. Schonberger, J. Marienhagen, A. Agha, S. Rozeboom, E. Bachmeier, H. Schlitt, C. Eilles, Papillary microcarcinoma and papillary cancer of the thyroid B1 cm. Modified definition of the WHO and the therapeutic dilemma. Nuklearmedizin 46, 115–120 (2007)PubMed
19.
Zurück zum Zitat S. Grodski, T. Brown, S. Sidhu, A. Gill, B. Robinson, D. Learoyd, M. Sywak, T. Reeve, L. Delbridge, Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery 144, 1038–1043 (2008)CrossRefPubMed S. Grodski, T. Brown, S. Sidhu, A. Gill, B. Robinson, D. Learoyd, M. Sywak, T. Reeve, L. Delbridge, Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery 144, 1038–1043 (2008)CrossRefPubMed
20.
Zurück zum Zitat E.L. Mazzaferri, J. Sipos, Should all patients with subcentimeter thyroid nodules undergo fine-needle aspiration biopsy and pre-operative neck ultrasonography to define the extent of tumor invasion? Thyroid 18, 597–602 (2008)CrossRefPubMed E.L. Mazzaferri, J. Sipos, Should all patients with subcentimeter thyroid nodules undergo fine-needle aspiration biopsy and pre-operative neck ultrasonography to define the extent of tumor invasion? Thyroid 18, 597–602 (2008)CrossRefPubMed
21.
Zurück zum Zitat M.R. Pelizzo, I.M. Boschin, A. Toniato, C. Pagetta, A. Piotto, P. Bernante, D. Casara, G. Pennelli, D. Rubello, Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience. Nucl. Med. Commun. 25, 547–552 (2004)CrossRefPubMed M.R. Pelizzo, I.M. Boschin, A. Toniato, C. Pagetta, A. Piotto, P. Bernante, D. Casara, G. Pennelli, D. Rubello, Natural history, diagnosis, treatment and outcome of papillary thyroid microcarcinoma (PTMC): a mono-institutional 12-year experience. Nucl. Med. Commun. 25, 547–552 (2004)CrossRefPubMed
22.
Zurück zum Zitat I. Sugitani, Y. Fujimoto, Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors. Endocr. J. 46, 209–216 (1999)CrossRefPubMed I. Sugitani, Y. Fujimoto, Symptomatic versus asymptomatic papillary thyroid microcarcinoma: a retrospective analysis of surgical outcome and prognostic factors. Endocr. J. 46, 209–216 (1999)CrossRefPubMed
23.
Zurück zum Zitat Q. Zhao, J. Ming, C. Liu, L. Shi, X. Xu, X. Nie, T. Huang, Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma. Ann. Surg. Oncol. 20, 746–752 (2013)CrossRefPubMed Q. Zhao, J. Ming, C. Liu, L. Shi, X. Xu, X. Nie, T. Huang, Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma. Ann. Surg. Oncol. 20, 746–752 (2013)CrossRefPubMed
24.
Zurück zum Zitat G. Lupoli, G. Vitale, M. Caraglia, M.R. Fittipaldi, A. Abbruzzese, P. Tagliaferri, A.R. Bianco, Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 353, 637–639 (1999)CrossRefPubMed G. Lupoli, G. Vitale, M. Caraglia, M.R. Fittipaldi, A. Abbruzzese, P. Tagliaferri, A.R. Bianco, Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet 353, 637–639 (1999)CrossRefPubMed
25.
Zurück zum Zitat G. Mercante, A. Frasoldati, C. Pedroni, D. Formisano, L. Renna, S. Piana, G. Gardini, R. Valcavi, V. Barbieri, Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid 19, 707–716 (2009)CrossRefPubMed G. Mercante, A. Frasoldati, C. Pedroni, D. Formisano, L. Renna, S. Piana, G. Gardini, R. Valcavi, V. Barbieri, Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid 19, 707–716 (2009)CrossRefPubMed
26.
Zurück zum Zitat J.S. Choi, E.-K. Kim, H.J. Moon, J.Y. Kwak, Higher body mass index may be a predictor of extrathyroidal extension in patients with papillary thyroid microcarcinoma. Endocrine (2014). doi:10.1007/s120120-014-0293-z J.S. Choi, E.-K. Kim, H.J. Moon, J.Y. Kwak, Higher body mass index may be a predictor of extrathyroidal extension in patients with papillary thyroid microcarcinoma. Endocrine (2014). doi:10.​1007/​s120120-014-0293-z
27.
Zurück zum Zitat H.J. Shin, E.-K. Kim, H.J. Moon, J.H. Yoon, K.-H. Han, J.Y. Kwak, Can increased tumoral vascularity be a quantitative predicting factor of lymph node metastasis in papillary thyroid microcarcinoma? Endocrine (2013). doi:10.1007/s12020-013-0131-8 PubMed H.J. Shin, E.-K. Kim, H.J. Moon, J.H. Yoon, K.-H. Han, J.Y. Kwak, Can increased tumoral vascularity be a quantitative predicting factor of lymph node metastasis in papillary thyroid microcarcinoma? Endocrine (2013). doi:10.​1007/​s12020-013-0131-8 PubMed
28.
Zurück zum Zitat T.Y. Kim, S.J. Hong, M. Kim, W.G. Kim, G. Gong, J.S. Ryu, W.B. Kim, S.-C. Yun, Y.K. Shong, Prognostic parameters for recurrence of papillary thyroid microcarcinoma. B.M.C. Cancer 8, 296 (2008)PubMedCentralPubMed T.Y. Kim, S.J. Hong, M. Kim, W.G. Kim, G. Gong, J.S. Ryu, W.B. Kim, S.-C. Yun, Y.K. Shong, Prognostic parameters for recurrence of papillary thyroid microcarcinoma. B.M.C. Cancer 8, 296 (2008)PubMedCentralPubMed
29.
Zurück zum Zitat E.J. Kuo, P. Goffredo, J.A. Sosa, S.A. Roman, Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph node metastases: a population-level analysis. Thyroid 23, 1305–1311 (2013)CrossRefPubMedCentralPubMed E.J. Kuo, P. Goffredo, J.A. Sosa, S.A. Roman, Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph node metastases: a population-level analysis. Thyroid 23, 1305–1311 (2013)CrossRefPubMedCentralPubMed
30.
Zurück zum Zitat K.L. Lin, O.C. Wang, X.H. Zhang, X.X. Dai, X.Q. Hu, J.M. Qu, The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma. Ann. Surg. Oncol. 17, 3294–3300 (2010)CrossRefPubMed K.L. Lin, O.C. Wang, X.H. Zhang, X.X. Dai, X.Q. Hu, J.M. Qu, The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma. Ann. Surg. Oncol. 17, 3294–3300 (2010)CrossRefPubMed
Metadaten
Titel
Nodal metastasis and recurrence in papillary thyroid microcarcinoma
verfasst von
Adolfo Pisanu
Alessandra Saba
Mauro Podda
Isabella Reccia
Alessandro Uccheddu
Publikationsdatum
01.03.2015
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2015
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0350-7

Weitere Artikel der Ausgabe 2/2015

Endocrine 2/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.